Scaffali intelligenti con sistemi RFID in banda UHF

Localizzazione di tag RFID all'interno di scaffali in banda UH

Investigations on low temperature laser-generated plasmas

AbstractA nanosecond pulsed Nd-Yag laser, operating at an intensity of about 109 W/cm2, was employed to irradiate different metallic solid targets (Al, Cu, Ta, W, and Au) in vacuum. The measured ablation yield increases with the direct current (dc) electrical conductivity of the irradiated target. The produced plasma was characterized in terms of thermal and Coulomb interaction evaluating the ion temperature and the ion acceleration voltage developed in the non-equilibrium plasma core. The particles emission produced along the normal to the target surface was investigated measuring the neutral and the ion energy distributions and fitting the experimental data with the "Coulomb-Boltzmann-shifted" function. Results indicate that the mean energy of the distributions and the equivalent ion acceleration voltage of the non-equilibrium plasma increase with the free electron density of the irradiated element

Ion acceleration enhancement in laser-generated plasmas by metallic doped hydrogenated polymers

Laser-generated plasmas in vacuum were obtained by ablating hydrogenated polymers at the Physics Department of the University of Messina and at the PALS Laboratory in Prague. In the first case a 3 ns, 532 nm Nd:Yag laser, at 10^10 W/cm^2 intensity was employed. In the second case a 300 ps, 438 nm iodine laser, at 5x10^14 W/cm^2 intensity was employed. Different ion collectors were used in a time-of-flight configuration to monitor the ejected ions from the plasma at different angles with respect to the direction normal to the target surface. Measurements demonstrated that the mean ion velocity, directed orthogonally to the target surface, increases for ablation of polymers doped with metallic elements with respect to the nondoped one. The possible mechanism explaining the results can be found in the different electron density of the plasma, due to the higher number of electrons coming from the doping elements. This charge enhancement increases the equivalent ion voltage acceleration, i.e. the electric field generated in the non-equilibrium plasma placed in front of the ablated target surface

Dynamic properties of buildings evaluated through ambient noise measurements

It is well known that the damage level and its distribution during an earthquake is due to the combined effects of seismic hazard in the investigated area, the features of the local site response, based on the near–surface and subsurface ground conditions, as well as on the dynamic features of the erected buildings. The extent of building dam- age and its distribution is indeed tightly linked to the combined effect of local site response and the dynamic features of the human-made structures. The dynamic properties of a building are usually described through its natural frequency (or period T) and the damping ratio (ζ ), the latter representing the energy loss of an oscillating system. The damping ratio is important in seismic design since it allows to evaluate the ability of a structure to dissipate the vibration energy during an earthquake. Such energy causes a structure to have the highest amplitude of response at its fundamental period, which depends on the structure’s mass and stiffness. The knowledge of damping level and fundamental period of the building is therefore particularly important for estimating the seismic base shear force F in designing earthquake resistant structures.peer-reviewe

HCV derived from sera of HCV-infected patients induces pro-fibrotic effects in human primary fibroblasts by activating GLI2

Hepatitis C virus (HCV) infection is a leading cause of liver fibrosis, especially in developing countries. The process is characterized by the excess accumulation of ECM that may lead, over time, to hepatic cirrhosis, liver failure and also to hepatocarcinoma. The direct role of HCV in promoting fibroblasts trans-differentiation into myofibroblasts, the major fibrogenic cells, has not been fully clarified. In this study, we found that HCV derived from HCV-infected patients infected and directly induced the trans-differentiation of human primary fibroblasts into myofibroblasts, promoting fibrogenesis. This effect correlated with the activation of GLI2, one of the targets of Hedgehog signaling pathway previously reported to be involved in myofibroblast generation. Moreover, GLI2 activation by HCV correlated with a reduction of autophagy in fibroblasts, that may further promoted fibrosis. GLI2 inhibition by Gant 61 counteracted the pro-fibrotic effects and autophagy inhibition mediated by HCV, suggesting that targeting HH/GLI2 pathway might represent a promising strategy to reduce the HCV-induced fibrosis

High intrinsic activity of the oxygen evolution reaction in low-cost NiO nanowall electrocatalysts

NiO nanowalls grown by low-cost chemical bath deposition and thermal annealing are a high-efficiency and sustainable electrocatalytst for OER

Correction: High intrinsic activity of the oxygen evolution reaction in low-cost NiO nanowall electrocatalysts

Correction for 'High intrinsic activity of the oxygen evolution reaction in low-cost NiO nanowall electrocatalysts' by Salvatore Cosentino et al., Mater. Adv., 2020, DOI: 10.1039/d0ma00467g

Osteoma del mascellare associato a cisti odontogena omolaterale: approccio chirurgico combinato.

L’osteoma osteoide è una lesione osteogenica benigna la cui localizzazione nel seno mascellare è piuttosto rara, appena 7 casi descritti negli ultimi 15 anni. Di più frequente riscontro, sono le cisti odontogene del mascellare. Il riscontro contestuale delle due patologie è un evento piuttosto raro. Descriviamo il caso di osteoma del mascellare associato a voluminosa cisti odontogena omolaterale a partenza dalla radice dell’11mo. La paziente (42a), giungeva alla nostra osservazione per ostruzione respiratoria nasale, cacosmia, rinorrea mucopurulenta ed epifora monolaterali. L’imaging evidenziava la presenza di entrambe le lesioni che occupavano interamente il seno mascellare destro. La paziente veniva indirizzata a chirurgia e si optava per un approccio endoscopico combinato con doppio accesso transorale e transnasale con exeresi delle lesioni e ricostruzione del pavimento del mascellare con ausilio di membrana con PRGF (plasma ricco di fattori di crescita). Nessuna complicanza peri e post-operatoria è stata osservata. Il caso in esame pone l’attenzione sull’approccio multidisciplinare alla patologia e sulla scelta di una tecnica chirurgica conservativa con utilizzo di PRGF

Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma

Patients with metastatic melanoma bearing V600 mutations in BRAF oncogene clinically benefit from the treatment with BRAF inhibitors alone or in combination with MEK inhibitors. However, a limitation to such treatment is the occurrence of resistance. Tackling the adaptive changes helping cells survive from drug treatment may offer new therapeutic opportunities. Very recently the ErbB3 receptor has been shown to act as a central node promoting survival of BRAF mutated melanoma. In this paper we first demonstrate that ErbB3/AKT hyperphosphorylation occurs in BRAF mutated melanoma cell lines following exposure to BRAF and/or MEK inhibitors. This strongly correlates with increased transcriptional activation of its ligand neuregulin. Anti-ErbB3 antibodies impair the establishment of de novo cell resistance to BRAF inhibition in vitro. In order to more potently ablate ErbB3 activity we used a combination of two anti-ErbB3 antibodies directed against distinct epitopes of its extracellular domain. These two antibodies in combo with BRAF/MEK inhibitors potently inhibit in vitro cell growth and tumor regrowth after drug withdrawal in an in vivo xenograft model. Importantly, residual tumor masses from mice treated by the antibodies and BRAF/ERK inhibitors combo are characterized almost exclusively by large necrotic areas with limited residual areas of tumor growth. Taken together, our findings support the concept that triple therapy directed against BRAF/MEK/ErbB3 may be able to provide durable control of BRAF mutated metastatic melanoma